Parkside Financial Bank & Trust’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-207
| Closed | -$6.87K | – | 2137 |
|
|
2022
Q4 | $6.87K | Buy |
207
+77
| +59% | +$2.48K | ﹤0.01% | 1192 |
|
|
2022
Q3 | $4K | Hold |
130
| – | – | ﹤0.01% | 1362 |
|
|
2022
Q2 | $4K | Hold |
130
| – | – | ﹤0.01% | 1394 |
|
|
2022
Q1 | $3K | Sell |
130
-27
| -17% | -$642 | ﹤0.01% | 1546 |
|
|
2021
Q4 | $3K | Buy |
157
+20
| +15% | +$383 | ﹤0.01% | 1556 |
|
|
2021
Q3 | $3K | Buy |
137
+69
| +101% | +$1.38K | ﹤0.01% | 1498 |
|
|
2021
Q2 | $2K | Buy |
68
+1
| +1% | +$21 | ﹤0.01% | 1600 |
|
|
2021
Q1 | $2K | Buy |
67
+3
| +5% | +$71 | ﹤0.01% | 1559 |
|
|
2020
Q4 | $1K | Buy |
64
+8
| +14% | +$149 | ﹤0.01% | 1585 |
|
|
2020
Q3 | $1K | Hold |
56
| – | – | ﹤0.01% | 1480 |
|
|
2020
Q2 | $1K | Hold |
56
| – | – | ﹤0.01% | 1430 |
|
|
2020
Q1 | $0 | Buy |
+56
| New | +$471 | ﹤0.01% | 1719 |
|
|
2019
Q3 | – | Sell |
-84
| Closed | -$1K | – | 1687 |
|
|
2019
Q2 | $1K | Sell |
84
-89
| -51% | -$1.07K | ﹤0.01% | 1519 |
|
|
2019
Q1 | $3K | Buy |
173
+130
| +302% | +$2.16K | ﹤0.01% | 1111 |
|
|
2018
Q4 | $1K | Hold |
43
| – | – | ﹤0.01% | 1376 |
|
|
2018
Q3 | $1K | Hold |
43
| – | – | ﹤0.01% | 1442 |
|
|
2018
Q2 | $1K | Hold |
43
| – | – | ﹤0.01% | 1436 |
|
|
2018
Q1 | $1K | Hold |
43
| – | – | ﹤0.01% | 1352 |
|
|
2017
Q4 | $1K | Hold |
43
| – | – | ﹤0.01% | 1272 |
|
|
2017
Q3 | $1K | Hold |
43
| – | – | ﹤0.01% | 1280 |
|
|
2017
Q2 | $1K | Hold |
43
| – | – | ﹤0.01% | 1307 |
|
|
2017
Q1 | $1K | Buy |
43
+9
| +26% | +$126 | ﹤0.01% | 1259 |
|
|
2016
Q4 | $1K | Buy |
+34
| New | +$597 | ﹤0.01% | 1262 |
|
Other funds holding VIVO
Parkside Financial Bank & Trust's VIVO Position: Q1 2023 in Review
Parkside Financial Bank & Trust sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 207 shares — an estimated $6.87K sold.
Parkside Financial Bank & Trust first reported a position in VIVO in Q4 2016 and held it in 23 quarters. The position peaked at $6.87K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Parkside Financial Bank & Trust reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 207 Meridian Bioscience Inc shares in Q1 2023, an estimated $6.87K.
- Parkside Financial Bank & Trust first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 23 quarters.
- Parkside Financial Bank & Trust's Meridian Bioscience Inc position peaked at $6.87K in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2023, filed 4 May 2023.